Simplify Logo

Full-Time

Sr. Product Marketing Manager

Confirmed live in the last 24 hours

Radformation

Radformation

51-200 employees

Automated cancer treatment planning software

Hardware
AI & Machine Learning
Healthcare

Compensation Overview

$150k - $155kAnnually

Expert

Remote in USA

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Market Research
Sales
Marketing
Requirements
  • Bachelor’s degree in Marketing, Business, related field or equivalent experience
  • 10+ years of product marketing experience in the radiation oncology industry, plus for additional experience in EMEA market
  • Exceptional written and verbal communication skills
  • Strong project management skills
  • Self motivated, collaborative, creative and analytical
  • Strong interpersonal skills
  • Some travel required
Responsibilities
  • Gain a deep understanding of the Radformation suite, vision and future roadmap and utilize storytelling skills to translate the value into compelling narratives that resonate with various segments.
  • Conduct market research to gather intelligence on customer preferences, market dynamics, and competitive positioning.
  • Analyze market data to identify opportunities for product differentiation and market expansion.
  • Develop presentations and materials that simplify intricate concepts and highlight the benefits of our products.
  • Works as a bridge between product management and customer to gather feedback to inform product improvements and innovation.
  • Participate in planning and execution of product launches, including go-to-market strategies.
  • Empower the sales team with competitive analysis, training and strategies to enhance their product knowledge and position our products effectively against competitors.
  • Collaborate with R&D, sales, and regulatory teams to ensure successful product introductions.
  • Build and maintain strong relationships with key customers, industry influencers, and thought leaders.

Radformation is a leader in the specialized field of intelligent automation software for cancer clinics, facilitating high-quality treatment plans and improved safety with their suite of FDA-cleared tools. Their products, which focus on areas like AI contouring and dose validation, not only save time and resources for healthcare providers but also enhance patient outcomes. The integration with existing technologies like Eclipse™ TPS showcases the company's commitment to seamless operational solutions in medical treatment environments.

Company Stage

Seed

Total Funding

$9.7M

Headquarters

New York City, New York

Founded

2016

Growth & Insights
Headcount

6 month growth

59%

1 year growth

59%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • The strategic partnership with Icon Group positions Radformation to significantly impact global cancer care through innovative workflows and advanced software solutions.
  • Regulatory clearances in multiple countries open up new markets, potentially leading to increased revenue and global influence.
  • The acquisition of Limbus AI and partnerships with companies like BVP Forge indicate a strong focus on innovation and continuous improvement in AI-driven cancer care solutions.

What critics are saying

  • The integration of Limbus AI's technology may present challenges in terms of compatibility and seamless operation within Radformation's existing systems.
  • The highly competitive nature of the healthcare technology sector means that Radformation must continuously innovate to maintain its market position.

What makes Radformation unique

  • Radformation's acquisition of Limbus AI enhances its AI-driven capabilities, setting it apart in the radiation oncology software market.
  • The company's focus on automation solutions for cancer care, such as AutoContour, significantly reduces treatment planning time, offering a clear advantage over traditional methods.
  • Radformation's global regulatory clearances in countries like Australia, Brazil, Canada, and Thailand demonstrate its commitment to meeting rigorous standards and expanding its international footprint.